{
    "2018-10-19": [
        [
            {
                "time": "2018-10-19",
                "original_text": "A股龙虎榜揭秘，机构抢筹这7股",
                "features": {
                    "keywords": [
                        "龙虎榜",
                        "机构",
                        "抢筹"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "股票市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-19",
                "original_text": "沃森生物龙虎榜数据",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "龙虎榜",
                        "数据"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-19",
                "original_text": "沃森生物：市值6天蒸发109亿 高管与股东计划增持不少于2亿元 连续下跌",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "市值蒸发",
                        "高管增持",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-19",
                "original_text": "10月19日早间公告集锦：沃森生物股东拟2亿元增持",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "股东增持",
                        "早间公告"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-19",
                "original_text": "沃森生物部分董监高和主要股东拟增持公司股票",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "董监高",
                        "股东增持"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-19",
                "original_text": "早间公告：沃森生物部分董监高拟增持不少于2亿元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "董监高",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}